Search Results - "FEENSTRA, T. L"

AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users by Vemer, P., Corro Ramos, I., van Voorn, G. A. K., Al, M. J., Feenstra, T. L.

“…Background A trade-off exists between building confidence in health-economic (HE) decision models and the use of scarce resources. We aimed to create a…”
Get full text

Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach by HOOGENDOORN, M, HOOGENVEEN, R. T, RUTTEN-VAN MÖLKEN, M. P, VESTBO, J, FEENSTRA, T. L

“…The aim of our study was to estimate the case fatality of a severe exacerbation from long-term survival data presented in the literature. A literature search…”
Get full text

Model and Empirical Data-Based Cost-Utility Studies of Continuous Glucose Monitoring in Individuals with Type 1 Diabetes: A Protocol of a Systematic Review on Methodology and Quality by de Jong, L. A., Li, X., Emamipour, S., van der Werf, S., Postma, M. J., van Dijk, P. R., Feenstra, T. L.

“…Introduction This review aims to critically appraise differences in methodology and quality of model-based and empirical-data-based cost-utility studies to…”
Get full text

Policy evaluation in diabetes prevention and treatment using a population-based macro simulation model: the MICADO model by van der Heijden, A. A. W. A., Feenstra, T. L., Hoogenveen, R. T., Niessen, L. W., de Bruijne, M. C., Dekker, J. M., Baan, C. A., Nijpels, G.

“…Aims To test a simulation model, the MICADO model, for estimating the long‐term effects of interventions in people with and without diabetes. Methods The…”
Get full text

A dynamic population model of disease progression in COPD by Hoogendoorn, M, Rutten-van Molken, M. P. M. H, Hoogenveen, R. T, van Genugten, M. L. L, Buist, A. S, Wouters, E. F. M, Feenstra, T. L

“…To contribute to evidence-based policy making, a dynamic Dutch population model of chronic obstructive pulmonary disease (COPD) progression was developed. The…”
Get full text

The relationship between diabetes, diabetes-related complications and productive activities among older Europeans by Rodriguez-Sanchez, B., Alessie, R. J. M., Feenstra, T. L., Angelini, V.

“…Aims To assess the impact of diabetes and diabetes-related complications on two measures of productivity for people in the labour force and out of it, namely…”
Get full text

Individual patient information to select patients for different radiation techniques by Quik, E.H, Feenstra, T.L, Postmus, D, Slotman, B.J, Leemans, C.R, Krabbe, P.F.M, Langendijk, J.A

“…Abstract Background and purpose Proton therapy is an emerging technique in radiotherapy which results in less dose to the normal tissues with similar target…”
Get full text

The design of a Social Cost‐Benefit Analysis of preventive interventions for toxoplasmosis: An example of the One Health approach by Suijkerbuijk, A. W. M., Gils, P. F., Bonačić Marinović, A. A., Feenstra, T. L., Kortbeek, L. M., Mangen, M.‐J. J., Opsteegh, M., Wit, G. A., Giessen, J. W. B.

“…Summary Toxoplasma gondii infections cause a large disease burden in the Netherlands, with an estimated health loss of 1,900 Disability Adjusted Life Years and…”
Get full text

The burden of asthma and chronic obstructive pulmonary disease: data from The Netherlands by Rutten van-Mölken, M P, Feenstra, T L

“…It is important to consider all aspects of the burden of a disease using a range of outcome measures - not only morbidity and mortality - but also the effect…”
Get full text

Communicating Uncertainty in Economic Evaluations: Verifying Optimal Strategies by Koffijberg, H., de Wit, G. A., Feenstra, T. L.

“…Background. In cost-effectiveness analysis (CEA), it is common to compare a single, new intervention with 1 or more existing interventions representing current…”
Get full text

Improving Model Validation in Health Technology Assessment: Comments on Guidelines of the ISPOR-SMDM Modeling Good Research Practices Task Force by Vemer, Pepijn, Krabbe, P.F.M, Feenstra, T.L, Van Voorn, G.A.K, Ramos, Corro, Al, M.J

Get full text

Prediction models for exacerbations in different COPD patient populations: comparing results of five large data sources by Hoogendoorn, Martine, Feenstra, Talitha L, Boland, Melinde, Briggs, Andrew H, Borg, Sixten, Jansson, Sven-Arne, Risebrough, Nancy A, Slejko, Julia F, Rutten-van Mölken, Maureen Pmh

“…Exacerbations are important outcomes in COPD both from a clinical and an economic perspective. Most studies investigating predictors of exacerbations were…”
Get full text

To screen or not to screen for breast cancer? How do modelling studies answer the question? by Koleva-Kolarova, R G, Zhan, Z, Greuter, M J W, Feenstra, T L, De Bock, G H

“…Breast cancer screening is a topic of hot debate, and currently no general consensus has been reached on starting and ending ages and screening intervals, in…”
Get full text

Potential reach of effective smoking prevention programmes in vocational schools: Determinants of school directors’ intention to adopt these programmes by Veldwijk, J, Hoving, C, van Gelder, B.M, Feenstra, T.L

“…Summary Objectives Investigating the current, intended and potential reach of two effective smoking prevention programs in Dutch vocational schools and…”
Get full text

The Impact of Aging and Smoking on the Future Burden of Chronic Obstructive Pulmonary Disease . A Model Analysis in the Netherlands by FEENSTRA, TALITHA L, van GENUGTEN, MARIANNE L. L, HOOGENVEEN, RUDOLF T, WOUTERS, EMIEL F, RUTTEN-van MOLKEN, MAUREEN P. M. H

“…Chronic obstructive pulmonary disease (COPD) causes extensive disability, primarily among the elderly. On the World Health Organization ranking list of…”
Get full text

Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation among Dutch students by Vijgen, S. M. C., van Baal, P. H. M., Hoogenveen, R. T., de Wit, G. A., Feenstra, T. L.

“…Little research has been done to connect health promotion programs to outcomes in terms of life expectancy, health care costs and cost-effectiveness. For a…”
Get full text

Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD by Hoogendoorn, Martine, Feenstra, Talitha L, Hoogenveen, Rudolf T, Rutten-van Mölken, Maureen P M H

“…The aim of this study was to estimate the long-term (cost-) effectiveness of smoking cessation interventions for patients with chronic obstructive pulmonary…”
Get more information

A social cost-benefit analysis of two One Health interventions to prevent toxoplasmosis by Suijkerbuijk, A W M, Over, E A B, Opsteegh, M, Deng, H, van Gils, P F, Marinovic, AA Bonacic, Lambooij, M, Polder, J J, Feenstra, T L, van der Giessen, J W B, de Wit, G A, Mangen, M J

“…Abstract Background In the Netherlands, toxoplasmosis ranks third in disease burden among foodborne pathogens, with an estimated health loss of 1,900…”
Get full text

Advishe: a New Tool to Report Validation of Health-Economic Decision Models by Vemer, P, Corro Ramos, I, Van Voorn, G, Al, M.J, Feenstra, T.L

Get full text

Reduction of smoking in Dutch adolescents over the past decade and its health gains: a repeated cross-sectional study by Gielkens-Sijstermans, Cindy M., Mommers, Monique A., Hoogenveen, Rudolf T., Feenstra, Talitha L., de Vreede, Jacqueline, Bovens, Fons M., van Schayck, Onno C.

“…Background: Smoking is the main preventable lifestyle-related risk factor threatening human health. In this study, time trends in smoking behaviour between…”
Get full text